The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...